Understanding how the body's internal clock affects the development of insulin-producing cells in the pancreas
Circadian Control of Pancreatic Beta-cell Maturation
['FUNDING_CAREER'] · UNIVERSITY OF PENNSYLVANIA · NIH-10887881
This study is looking at how a protein called Dec1 helps insulin-producing cells in the pancreas mature according to our body's natural clock, with the hope of finding better treatments for people with type 1 and type 2 diabetes.
Quick facts
| Phase | ['FUNDING_CAREER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF PENNSYLVANIA (nih funded) |
| Locations | 1 site (PHILADELPHIA, UNITED STATES) |
| Trial ID | NIH-10887881 on ClinicalTrials.gov |
What this research studies
This research investigates how pancreatic beta cells, which produce insulin, mature in response to the body's circadian rhythms. The study focuses on a specific protein called Dec1, which plays a crucial role in this maturation process. By examining the effects of Dec1 on the genetic and molecular changes in beta cells, the research aims to uncover new insights that could help improve treatments for diabetes. The ultimate goal is to enhance the function of these cells, potentially leading to better therapies for patients with type 1 and type 2 diabetes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with type 1 or type 2 diabetes who may benefit from advancements in insulin production and secretion.
Not a fit: Patients who do not have diabetes or related metabolic disorders may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for diabetes by enhancing the function of insulin-producing cells.
How similar studies have performed: Previous research has shown promising results in understanding the maturation of pancreatic beta cells, indicating that this approach could yield significant insights.
Where this research is happening
PHILADELPHIA, UNITED STATES
- UNIVERSITY OF PENNSYLVANIA — PHILADELPHIA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ALVAREZ, JUAN R — UNIVERSITY OF PENNSYLVANIA
- Study coordinator: ALVAREZ, JUAN R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.